Stay updated on Stereotactic RT+Pembrolizumab in Oligometastatic Renal Cancer Clinical Trial

Sign up to get notified when there's something new on the Stereotactic RT+Pembrolizumab in Oligometastatic Renal Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Stereotactic RT+Pembrolizumab in Oligometastatic Renal Cancer Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    Revision: v3.5.0 was added and Revision: v3.4.3 was removed.
    Difference
    0.1%
    Check dated 2026-03-19T06:40:41.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-12T00:30:43.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    30 days ago
    Change Detected
    Summary
    No additions or deletions were detected on the page.
    Difference
    0.1%
    Check dated 2026-02-25T18:23:41.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2. Removed older notices about government funding lapse and NIH Clinical Center operating status; users are directed to opm.gov for current status updates.
    Difference
    0.4%
    Check dated 2026-02-11T13:59:37.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    Added a government funding lapse notice and updated the revision tag from v3.4.0 to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-04T10:13:25.000Z thumbnail image
  8. Check
    59 days ago
    Change Detected
    Summary
    Added a 'Show glossary' option and standardized several footer/labels: 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and updated the Revision tag to v3.4.0 (from v3.3.4).
    Difference
    0.2%
    Check dated 2026-01-28T04:48:14.000Z thumbnail image

Stay in the know with updates to Stereotactic RT+Pembrolizumab in Oligometastatic Renal Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Stereotactic RT+Pembrolizumab in Oligometastatic Renal Cancer Clinical Trial page.